| Year |
Citation |
Score |
| 2016 |
Gimbel J, Spierings EL, Katz N, Xiang Q, Tzanis E, Finn A. Efficacy and Tolerability of Buccal Buprenorphine in Opioid-Experienced Patients With Moderate to Severe Chronic Low Back Pain: Results of a Phase 3, Enriched Enrollment, Randomized Withdrawal Study. Pain. PMID 27434505 DOI: 10.1097/j.pain.0000000000000670 |
0.392 |
|
| 2016 |
Webster LR, Camilleri M, Finn A. Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals. Substance Abuse and Rehabilitation. 7: 81-6. PMID 27366109 DOI: 10.2147/SAR.S100998 |
0.598 |
|
| 2016 |
Webster L, Gruener D, Kirby T, Xiang Q, Tzanis E, Finn A. Evaluation of the Tolerability of Switching Patients on Chronic Full μ-Opioid Agonist Therapy to Buccal Buprenorphine. Pain Medicine (Malden, Mass.). 17: 899-907. PMID 26917621 DOI: 10.1093/pm/pnv110 |
0.621 |
|
| 2016 |
Bai SA, Xiang Q, Finn A. Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers. Clinical Therapeutics. 38: 358-69. PMID 26804639 DOI: 10.1016/j.clinthera.2015.12.016 |
0.327 |
|
| 2016 |
Darpo B, Zhou M, Bai SA, Ferber G, Xiang Q, Finn A. Differentiating the Effect of an Opioid Agonist on Cardiac Repolarization From µ-Receptor-mediated, Indirect Effects on the QT Interval: A Randomized, 3-way Crossover Study in Healthy Subjects. Clinical Therapeutics. 38: 315-26. PMID 26749217 DOI: 10.1016/j.clinthera.2015.12.004 |
0.535 |
|
| 2015 |
Rauck RL, Potts J, Xiang Q, Tzanis E, Finn A. Efficacy and Tolerability of Buccal Buprenorphine in Opioid-Naive Patients With Moderate to Severe Chronic Low Back Pain. Postgraduate Medicine. PMID 26634956 DOI: 10.1080/00325481.2016.1128307 |
0.364 |
|
| 2015 |
Webster LR, Smith MD, Unal C, Finn A. Low-dose naloxone provides an abuse-deterrent effect to buprenorphine. Journal of Pain Research. 8: 791-798. PMID 26604818 DOI: 10.2147/Jpr.S90780 |
0.319 |
|
| Show low-probability matches. |